1
|
Huang L, Zheng Y, Yuan X, Ma Y, Xie G,
Wang W, Chen H and Shen L: Decreased frequencies and impaired
functions of the CD31+ subpopulation in Treg
cells associated with decreased FoxP3 expression and enhanced
Treg cell defects in patients with coronary heart
disease. Clin Exp Immunol. 187:441–454. 2017. View Article : Google Scholar
|
2
|
Jokinen E: Coronary artery disease in
patients with congenital heart defects. J Intern Med. 288:383–389.
2020. View Article : Google Scholar : PubMed/NCBI
|
3
|
Malakar AK, Choudhury D, Halder B, Paul P,
Uddin A and Chakraborty S: A review on coronary artery disease, its
risk factors, and therapeutics. J Cell Physiol. 234:16812–16823.
2019. View Article : Google Scholar : PubMed/NCBI
|
4
|
Valgimigli M, Bueno H, Byrne RA, Collet
JP, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, et
al: 2017 ESC focused update on dual antiplatelet therapy in
coronary artery disease developed in collaboration with EACTS: The
Task Force for dual antiplatelet therapy in coronary artery disease
of the European Society of Cardiology (ESC) and of the European
association for cardio-thoracic surgery (EACTS). Eur Heart J.
39:213–260. 2018. View Article : Google Scholar
|
5
|
Cai Y, Yang Y, Chen X, Wu G, Zhang X, Liu
Y, Yu J, Wang X, Fu J, Li C, et al: Circulating 'lncRNA
OTTHUMT00000387022' from monocytes as a novel biomarker for
coronary artery disease. Cardiovasc Res. 112:714–724. 2016.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Huang Y: The novel regulatory role of
lncRNA-miRNA-mRNA axis in cardiovascular diseases. J Cell Mol Med.
22:5768–5775. 2018. View Article : Google Scholar : PubMed/NCBI
|
7
|
Bhan A and Mandal SS: LncRNA HOTAIR: A
master regulator of chromatin dynamics and cancer. Biochim Biophys
Acta. 1856:151–164. 2015.PubMed/NCBI
|
8
|
Derrien T, Johnson R, Bussotti G, Tanzer
A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG,
et al: The GENCODE v7 catalog of human long noncoding RNAs:
Analysis of their gene structure, evolution, and expression. Genome
Res. 22:1775–1789. 2012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Sanfilippo PG and Hewitt AW: Translating
the ENCyclopedia Of DNA elements project findings to the clinic:
ENCODE's implications for eye disease. Clin Exp Ophthalmol.
42:78–83. 2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
11
|
Kaikkonen MU, Lam MT and Glass CK:
Non-coding RNAs as regulators of gene expression and epigenetics.
Cardiovasc Res. 90:430–440. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Greco S, Gorospe M and Martelli F:
Noncoding RNA in age-related cardiovascular diseases. J Mol Cell
Cardiol. 83:142–155. 2015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Li L, Wang L, Li H, Han X, Chen S, Yang B,
Hu Z, Zhu H, Cai C, Chen J, et al: Characterization of LncRNA
expression profile and identification of novel LncRNA biomarkers to
diagnose coronary artery disease. Atherosclerosis. 275:359–367.
2018. View Article : Google Scholar : PubMed/NCBI
|
14
|
Zhang H, Ji N, Gong X, Ni S and Wang Y:
NEAT1/miR-140-3p/MAPK1 mediates the viability and survival of
coronary endothelial cells and affects coronary atherosclerotic
heart disease. Acta Biochim Biophys Sin (Shanghai). 52:967–974.
2020. View Article : Google Scholar
|
15
|
Zhang Z, Gao W, Long QQ, Zhang J, Li YF,
Liu DC, Yan JJ, Yang ZJ and Wang LS: Increased plasma levels of
lncRNA H19 and LIPCAR are associated with increased risk of
coronary artery disease in a Chinese population. Sci Rep.
7:74912017. View Article : Google Scholar : PubMed/NCBI
|
16
|
Tang Y, Jin X, Xiang Y, Chen Y, Shen CX,
Zhang YC and Li YG: The lncRNA MALAT1 protects the endothelium
against ox-LDL-induced dysfunction via upregulating the expression
of the miR-22-3p target genes CXCR2 and AKT. FEBS Lett.
589:3189–3196. 2015. View Article : Google Scholar : PubMed/NCBI
|
17
|
Michalik KM, You X, Manavski Y,
Doddaballapur A, Zörnig M, Braun T, John D, Ponomareva Y, Chen W,
Uchida S, et al: Long noncoding RNA MALAT1 regulates endothelial
cell function and vessel growth. Circ Res. 114:1389–1397. 2014.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Motterle A, Pu X, Wood H, Xiao Q, Gor S,
Ng FL, Chan K, Cross F, Shohreh B, Poston RN, et al: Functional
analyses of coronary artery disease associated variation on
chromosome 9p21 in vascular smooth muscle cells. Hum Mol Genet.
21:4021–4029. 2012. View Article : Google Scholar : PubMed/NCBI
|
19
|
Ivanov D, Philippova M, Allenspach R, Erne
P and Resink T: T-cadherin upregulation correlates with cell-cycle
progression and promotes proliferation of vascular cells.
Cardiovasc Res. 64:132–143. 2004. View Article : Google Scholar : PubMed/NCBI
|
20
|
Wang G, Li Y, Peng Y, Tang J and Li H:
Association of polymorphisms in MALAT1 with risk of coronary
atherosclerotic heart disease in a Chinese population. Lipids
Health Dis. 17:752018. View Article : Google Scholar : PubMed/NCBI
|
21
|
Wu Z, He Y, Li D, Fang X, Shang T, Zhang H
and Zheng X: Long noncoding RNA MEG3 suppressed endothelial cell
proliferation and migration through regulating miR-21. Am J Transl
Res. 9:3326–3335. 2017.PubMed/NCBI
|
22
|
Li P, Yan X, Xu G, Pang Z, Weng J, Yin J,
Li M, Yu L, Chen Q and Sun K: A novel plasma lncRNA ENST00000416361
is upregulated in coronary artery disease and is related to
inflammation and lipid metabolism. Mol Med Rep. 21:2375–2384.
2020.PubMed/NCBI
|
23
|
Wenger NK: 2011 ACCF/AHA focused update of
the guidelines for the management of patients with unstable
angina/Non-ST-elevation myocardial infarction (updating the 2007
guideline): Highlights for the clinician. Clin Cardiol. 35:3–8.
2012. View Article : Google Scholar
|
24
|
Jia Y, Xu H, Li Y, Wei C, Guo R, Wang F,
Wu Y, Liu J, Jia J, Yan J, et al: A modified ficoll-paque gradient
method for isolating mononuclear cells from the peripheral and
umbilical cord blood of humans for biobanks and clinical
laboratories. Biopreserv Biobank. 16:82–91. 2018. View Article : Google Scholar
|
25
|
Trapnell C, Hendrickson DG, Sauvageau M,
Goff L, Rinn JL and Pachter L: Differential analysis of gene
regulation at transcript resolution with RNA-seq. Nat Biotechnol.
31:46–53. 2013. View Article : Google Scholar
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
27
|
Wang L, Feng Z, Wang X, Wang X and Zhang
X: DEGseq: An R package for identifying differentially expressed
genes from RNA-seq data. Bioinformatics. 26:136–138. 2010.
View Article : Google Scholar
|
28
|
Liu H, Lei C, He Q, Pan Z, Xiao D and Tao
Y: Nuclear functions of mammalian MicroRNAs in gene regulation,
immunity and cancer. Mol Cancer. 17:642018. View Article : Google Scholar : PubMed/NCBI
|
29
|
Wang Y, Tao B, Li J, Mao X, He W and Chen
Q: Melatonin inhibits the progression of oral squamous cell
carcinoma via inducing miR-25-5p expression by directly targeting
NEDD9. Front Oncol. 10:5435912020. View Article : Google Scholar :
|
30
|
Zhang Q, Liu C, Li Q, Li J, Wu Y and Liu
J: MicroRNA-25-5p counteracts oxidized LDL-induced pathological
changes by targeting neuronal growth regulator 1 (NEGR1) in human
brain micro-vessel endothelial cells. Biochimie. 165:141–149. 2019.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Niccoli G, Montone RA, Sabato V and Crea
F: Role of allergic inflammatory cells in coronary artery disease.
Circulation. 138:1736–1748. 2018. View Article : Google Scholar : PubMed/NCBI
|
32
|
Weber C and Noels H: Atherosclerosis:
Current pathogenesis and therapeutic options. Nat Med.
17:1410–1422. 2011. View Article : Google Scholar : PubMed/NCBI
|
33
|
Knorr M, Münzel T and Wenzel P: Interplay
of NK cells and monocytes in vascular inflammation and myocardial
infarction. Front Physiol. 5:2952014. View Article : Google Scholar : PubMed/NCBI
|
34
|
Jaipersad AS, Shantsila A, Lip GY and
Shantsila E: Expression of monocyte subsets and angiogenic markers
in relation to carotid plaque neovascularization in patients with
pre-existing coronary artery disease and carotid stenosis. Ann Med.
46:530–538. 2014. View Article : Google Scholar : PubMed/NCBI
|
35
|
Yang T, Chen T, Li Y, Gao L, Zhang S, Wang
T and Chen M: Downregulation of miR-25 modulates non-small cell
lung cancer cells by targeting CDC42. Tumour Biol. 36:1903–1911.
2015. View Article : Google Scholar
|
36
|
Wang C, Wang X, Su Z, Fei H, Liu X and Pan
Q: MiR-25 promotes hepatocellular carcinoma cell growth, migration
and invasion by inhibiting RhoGDI1. Oncotarget. 6:36231–36244.
2015. View Article : Google Scholar : PubMed/NCBI
|
37
|
Jung JH, Shin EA, Kim JH, Sim DY, Lee H,
Park JE, Lee HJ and Kim SH: NEDD9 inhibition by miR-25-5p
activation is critically involved in co-treatment of melatonin- and
pterostilbene-induced apoptosis in colorectal cancer cells. Cancers
(Basel). 11:16842019. View Article : Google Scholar
|
38
|
Yao Y, Song T, Xiong G, Wu Z, Li Q, Xia H
and Jiang X: Combination of peripheral blood mononuclear cell
miR-19b-5p miR-221, miR-25-5p and hypertension correlates with an
increased heart failure risk in coronary heart disease patients.
Anatol J Cardiol. 20:100–109. 2018.PubMed/NCBI
|
39
|
Wu JB, Ye XH, Xian SX and Dong MG:
Expressions of SERCA2a and miR-25-3p/5p in myocardium of rats with
heart failure and therapeutic effects of Xiefei Lishui recipe.
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 33:146–150. 2017.In
Chinese. PubMed/NCBI
|
40
|
Meseure D, Drak Alsibai K, Nicolas A,
Bieche I and Morillon A: Long noncoding RNAs as new architects in
cancer epigenetics, prognostic biomarkers, and potential
therapeutic targets. Biomed Res Int. 2015:3202142015. View Article : Google Scholar : PubMed/NCBI
|
41
|
Rizzacasa B, Amati F, Romeo F, Novelli G
and Mehta JL: Epigenetic modification in coronary atherosclerosis:
JACC review topic of the week. J Am Coll Cardiol. 74:1352–1365.
2019. View Article : Google Scholar : PubMed/NCBI
|
42
|
Zhang YH, Pan X, Zeng T, Chen L, Huang T
and Cai YD: Identifying the RNA signatures of coronary artery
disease from combined lncRNA and mRNA expression profiles.
Genomics. 112:4945–4958. 2020. View Article : Google Scholar : PubMed/NCBI
|